OptymEdge – part of the Emmes Group – have unveiled an enhancement to its ophthalmology services with the launch of the "clinical research industry’s first technology platform" dedicated solely to ophthalmology trials.
Aptamer Group presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).
Honeywell has introduced TrackWise Recall Management, a cloud-based artificial intelligence (AI)-assisted platform that redefines how life sciences manufacturers proactively manage product recalls in order to improve patient safety.
Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rapid and automated plasmid DNA isolation, enabling scientists to conduct small-scale experiments quickly.
Best Formulations, a Sirio Pharma Company (Sirio), a nutraceutical contract development and manufacturing organisation (CDMO), has successfully completed its National Sanitation Foundation (NSF) recertification audit.
Moleculin Biotech, a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, has announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application.
Aenova, a contract development and manufacturing organisation (CDMO) in the global pharmaceutical supply chain, announces the launch of its Aenovation program.
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has revealed the keynote speakers for its event, Drug Discovery 2025.
Enflex, a brand under Volpak, a Coesia company, specialising in packaging solutions for the pharmaceutical and healthcare sectors, will be presenting the new Enflex PH-28 at Pharmintech 2025.
